Deals Of The Week: Novartis/Penn, MEI Pharma/SBIO, Cempra/Curetis
It seems obvious on its face, but is there an actual link between biopharma companies’ stock prices and the release of new clinical trial data, either positive or negative?
It seems obvious on its face, but is there an actual link between biopharma companies’ stock prices and the release of new clinical trial data, either positive or negative?